Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Parkinson Disease 2”

365 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 365 results

Early research (Phase 1)Study completedNCT01964573
What this trial is testing

Trial to Evaluate the Pharmacokinetics, Safety, and Tolerability of Rotigotine in Healthy Korean Subjects

Who this might be right for
Parkinson's Disease
UCB Pharma 48
Testing effectiveness (Phase 2)Study completedNCT01171313
What this trial is testing

A Efficacy, Safety and Pharmacokinetic Study of XP21279 and Sinemet® in Parkinson's Disease Subjects

Who this might be right for
Parkinson's Disease
XenoPort, Inc. 35
Early research (Phase 1)Ended earlyNCT03739138
What this trial is testing

Intratumoral/Intralesional Administration of MK-4621/JetPEI™ With or Without Pembrolizumab in Participants With Advanced/Metastatic or Recurrent Solid Tumors (MK-4621-002)

Who this might be right for
Advanced Solid Tumors
Merck Sharp & Dohme LLC 30
Testing effectiveness (Phase 2)Study completedNCT02853344
What this trial is testing

Study of Pembrolizumab (MK-3475) Monotherapy in Locally Advanced/Metastatic Renal Cell Carcinoma (MK-3475-427/KEYNOTE-427)

Who this might be right for
Renal Cell Carcinoma
Merck Sharp & Dohme LLC 275
Testing effectiveness (Phase 2)Active Not RecruitingNCT06041802
What this trial is testing

Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) (Pembrolizumab Formulated With Berahyaluronidase Alfa (MK-5180)) in Japanese Participants With Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (R/M cSCC) or Locally Advanced (LA) Unresectable cSCC (MK-3475A-E39)

Who this might be right for
Squamous Cell Carcinoma
Merck Sharp & Dohme LLC 19
Large-scale testing (Phase 3)Study completedNCT02091739
What this trial is testing

Clinical Study to Investigate the Efficacy and Safety of Two Dose Levels of NT 201 Versus Placebo in Treating Chronic Troublesome Sialorrhea in Various Neurological Conditions

Who this might be right for
Chronic Troublesome SialorrheaParkinson's DiseasePost-stroke+1 more
Merz Pharmaceuticals GmbH 184
Testing effectiveness (Phase 2)Looking for participantsNCT07252739
What this trial is testing

KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)

Who this might be right for
Malignant Neoplasm
Merck Sharp & Dohme LLC 140
Large-scale testing (Phase 3)Study completedNCT03517449
What this trial is testing

Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775])

Who this might be right for
Endometrial Neoplasms
Eisai Inc. 827
Not applicableUnknownNCT04046276
What this trial is testing

Intensity of Aerobic Training and Neuroprotection in Parkinson's Disease

Who this might be right for
Parkinson's Disease
Assistance Publique - Hôpitaux de Paris 69
Post-approval studies (Phase 4)Study completedNCT03521635
What this trial is testing

The SUSTAIN Study Compares the Effects of Sustained and Immediate-release Pramipexole on the noctUrnal Symptoms of paTients With Advanced ParkInsoN's Disease Who Also Take L-Dopa

Who this might be right for
Parkinson Disease
Boehringer Ingelheim 98
Not applicableActive Not RecruitingNCT05779839
What this trial is testing

Caregiver Connections Via Technology in Dementia

Who this might be right for
Caregiver StressDementiaAlzheimer Disease+3 more
Mayo Clinic 355
Early research (Phase 1)Study completedNCT02604914
What this trial is testing

A Sequential Two-Part, Open-Label Study in Healthy Male and Female Subjects

Who this might be right for
Parkinson's Disease
NeuroDerm Ltd. 36
Large-scale testing (Phase 3)Active Not RecruitingNCT03765918
What this trial is testing

Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)

Who this might be right for
Head and Neck Neoplasms
Merck Sharp & Dohme LLC 714
Testing effectiveness (Phase 2)Study completedNCT01617135
What this trial is testing

Safety, Pharmacokinetics and Efficacy Study of CVT-301 Inpatients With Parkinson's Disease and "Off" Episodes

Who this might be right for
Idiopathic Parkinson's Disease
Acorda Therapeutics 25
Large-scale testing (Phase 3)Study completedNCT03713593
What this trial is testing

Safety and Efficacy of Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) Versus Lenvatinib as First-line Therapy in Participants With Advanced Hepatocellular Carcinoma (MK-7902-002/E7080-G000-311/LEAP-002)

Who this might be right for
Carcinoma, Hepatocellular
Merck Sharp & Dohme LLC 794
Not applicableLooking for participantsNCT06617884
What this trial is testing

Home-based Gait and Balance Training in Patients With Movement Disorders

Who this might be right for
AtaxiaParkinson Disease
Forschungszentrum Juelich 80
Not applicableUnknownNCT04719468
What this trial is testing

PD-Ballet: Effectiveness and Implementation in Parkinson's Disease

Who this might be right for
Parkinson Disease
King's College Hospital NHS Trust 160
Testing effectiveness (Phase 2)Active Not RecruitingNCT05819359
What this trial is testing

Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD

Who this might be right for
Parkinson's Disease
Bial R&D Investments, S.A. 237
Not applicableStudy completedNCT01817088
What this trial is testing

Sub-thalamic Nucleus Stimulation in Parkinson Disease

Who this might be right for
Parkinson's Disease
University Hospital, Bordeaux 30
Early research (Phase 1)Study completedNCT04625361
What this trial is testing

Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC122505MsOH Tablets in Healthy Adult Subjects

Who this might be right for
Parkinson Disease
Sunshine Lake Pharma Co., Ltd. 106
Next Page